Magnetic fields can control bacteria
Queen’s University researchers are using magnetic fields to influence a specific type of bacteria to swim against strong currents, opening up the potential of using the microscopic organisms for drug delivery in environments with complex microflows – like the human bloodstream.
Brain stimulation system receives FDA Approval
Boston Scientific has announced that it has received approval from the US FDA for the Vercise Deep Brain Stimulation (DBS) System. DBS is used to treat the symptoms of Parkinson's disease (PD), a degenerative condition that affects more than one million people in the United States and ten million worldwide. DBS works by stimulating a targeted region of the brain through implanted leads that are powered by a device called an implantable pulse...
May the Force be with you
Luke Skywalker’s bionic hand is a step closer to reality for amputees in this galaxy. Researchers at the Georgia Institute of Technology have created an ultrasonic sensor that allows amputees to control each of their prosthetic fingers individually. It provides fine motor hand gestures that aren’t possible with current commercially available devices. The first amputee to use it, a musician who lost part of his right arm five year...
3D-printed implants could improve hearing loss treatments
Researchers using CT scans and 3D printing have created accurate, custom-designed prosthetic replacements for damaged parts of the middle ear, according to a study being presented today at the annual meeting of the Radiological Society of North America (RSNA). The technique has the potential to improve a surgical procedure that often fails because of incorrectly sized prosthetic implants, researchers said.
Needle-free drug injector gets commercialisation agreement
Certain treatments for patients suffering from chronic diseases, such as inflammatory bowel diseases, require multiple intravenous or subcutaneous injections of specific drugs. Because of the pain and anxiety associated with needles, some patients stop adhering to treatments. MIT spinout Portal Instruments has now landed a commercialisation deal for a smart, needle-free injection device that could reduce the pain and anxiety associated with ...
Towards personalised treatment for lung cancer
Research aims to identify and characterise resistant lung cancer stem cells, and develop a model to customise drugs that can eradicate all cancer cells of an individual patient. This is the goal of researcher Mattias Magnusson, who received SEK 6 million from the Sjöberg Foundation to conduct this research project. Every year, close to 4 000 people in Sweden develop lung cancer. It is the fifth most common form of cancer in the country ...
Video game system helps physical therapists
Motion-based lab technology can help physical therapists, clinicians and athletic trainers analyse how we move—it also is very expensive. Some motion labs can cost upward of $100,000. Now, a team of University of Missouri researchers is finding that the depth camera often associated with video game systems can provide a variety of health care providers with objective information to improve patient care.
Drug could slow progress of Huntington's disease
The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial, and successfully lowered the level of the harmful huntingtin protein in the nervous system. After over a decade in pre-clinical development, this first human trial of huntingtin-lowering drug began in late 2015, led by Professor Sarah Tabrizi (UCL Institute of Neurology) and sponsored by Ionis Pharmaceuticals.
Computer model sheds light on sudden cardiac death
Some heart disease patients face a higher risk of sudden cardiac death, which can happen when an arrhythmia—an irregular heartbeat—disrupts the normal electrical activity in the heart and causes the organ to stop pumping. However, arrhythmias linked to sudden cardiac death are very rare, making it difficult to study how they occur—and how they might be prevented.
BioMimics: highly realistic 3D-printed models of human anatomy
Stratasys has unveiled BioMimics – a highly advanced capability to 3D print medical models that are engineered to meet demands of the industry’s leading hospitals, researchers and medical device manufacturers. Offered initially in North America as a service through Stratasys Direct Manufacturing, BioMimics provides incredibly realistic, functionally-accurate 3D printed replicas of complex anatomical structures - empowering more effect...